A "Pending patent application" published at the USPTO today:
http://appft1.uspto.gov/netacgi/nph-Parser...0506+AND+ACN/au)
United States Patent Application..20100113337
Kind Code A1
Wolgen; Philippe
May 6, 2010
METHOD FOR REDUCING INCIDENCE OR RATE OF DEVELOPMENT OF SKIN CANCERS AND RELATED CONDITIONS
Abstract
A method for treatment to reduce the incidence or rate of development of skin cancers and related conditions caused by or exacerbated by or associated with UVR-induced skin damage in an immuno-compromised subject, such as an organ transplant patient, comprises the step of administering to said subject an amount of an alpha-MSH analogue effective to protect the skin of the subject from UVR-induced skin damage.
Inventors:Wolgen; Philippe; (Melbourne, AU)
Correspondence Name and Address:
POLSINELLI SHUGHART PC 700 W. 47TH STREET, SUITE 1000 KANSAS CITY MO 64112-1802 US
Assignee Name and Address:
Clinuvel Pharmaceuticals Limited Melbourne (AU)
- Forums
- ASX - By Stock
- from the uspto today
A "Pending patent application" published at the USPTO...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.55 |
Change
-0.170(1.15%) |
Mkt cap ! $728.6M |
Open | High | Low | Value | Volume |
$15.00 | $15.00 | $14.27 | $1.051M | 72.59K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 293 | $14.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.59 | 293 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 293 | 14.400 |
1 | 293 | 14.370 |
1 | 293 | 14.350 |
1 | 293 | 14.320 |
3 | 1582 | 14.290 |
Price($) | Vol. | No. |
---|---|---|
14.590 | 293 | 1 |
14.610 | 293 | 1 |
14.640 | 293 | 1 |
14.670 | 1584 | 4 |
14.950 | 500 | 1 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |